COMP <GO>
NNNN vs TKNO // RSI-14 & 200D SMA MOMENTUM
Anbio Biotechnology (Class A) (NASDAQ) VS. Alpha Teknova Inc. (NASDAQ) • 15-METRIC TALLY: NNNN 6
— TKNO 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TKNO
LAST: $3.36 (-9.68%) • MKT CAP: $535.3M
rsi-technicals
37.9
LAST: $7.36 (-9.02%) • MKT CAP: $499.2M
rsi-technicals
54.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NNNN VS. TKNO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NNNN | TKNO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.20% | 33.20% | +54.00 | NNNN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.00% | -21.30% | +38.30 | NNNN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 91.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.26% | -1.96% | +0.70 | NNNN | /fcf-yield <GO> |
| Operating Margin | 66.70% | -41.90% | +108.60 | NNNN | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -42.60% | +110.60 | NNNN | /net-margins <GO> |
| Revenue Growth (YoY) | 5.60% | 7.40% | -1.80 | TKNO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 6.93 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 37.9 | 54.6 | -16.70 | TKNO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 77.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $535.3M | $499.2M | $36.1M | NNNN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NNNN REV | TKNO REV | NNNN GROSS % | TKNO GROSS % | NNNN FCF | TKNO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.6M | $40.5M | 87.2% | 33.2% | -$6.7M | -$9.8M |
| FY 2024 | $8.2M | $37.7M | 71.9% | 19.2% | $2.1M | -$13.5M |
| FY 2023 | $6.7M | $36.7M | — | — | $898.4K | -$18.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NNNN // BETA —
TKNO // BETA —